<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"MicroRNA-146a":1,
"NF-kB":1,
"PRKCE":1,
"papillary thyroid tumor":1,
"meta-analysis":6,
"minimally invasive":1,
"robotic":1,
"thyroidectomy":7,
"transaxillary":1,
"MALT lymphoma":1,
"amyloidosis":1,
"aspiration cytology":1,
"plasmacytoma":1,
"thyroid":14,
"TTF-1":3,
"fine needle aspiration":4,
"lung adenocarcinoma":2,
"thyroglobulin":4,
"thyroid carcinoma":6,
"Absorbed dose":1,
"Cobalt 60":1,
"Effective dose":1,
"Prostate cancer":1,
"TLD100":1,
"Water phantom":1,
"TSH":1,
"papillary thyroid carcinoma":17,
"risk factors":2,
"thyroid neoplasm":1,
"thyroid nodule":9,
"incidental":1,
"management":1,
"nodules":1,
"outcomes":1,
"biopsy, fine-needle":1,
"cytological techniques":1,
"neoplasms by histologic type":1,
"thyroid cancer, papillary":2,
"thyroid neoplasms":6,
"Cowden-like syndrome":1,
"neck paraganglioma":1,
"papillary thyroid cancer":5,
"pituitary adenoma":2,
"prolactinoma":1,
"(131)I-Iodide":1,
"Cáncer folicular de tiroides":1,
"Enfermedad metastásica":1,
"Follicular thyroid cancer":1,
"Metastatic disease":2,
"Radioiodine therapy":1,
"SPECT":1,
"Terapia con yodo radioactivo":1,
"Yodo radioactivo (131)I":1,
"Carcinogen":1,
"M phase":1,
"Rat":1,
"Two-stage carcinogenesis model":1,
"p21(Cip1)":1,
"Bethesda System for Reporting Thyroid Cytopathology":2,
"follicular lesion of undetermined significance (FLUS)":1,
"follicular-pattern":1,
"papillary carcinoma":3,
"central lymph node metastasis":2,
"lateral lymph node metastasis":1,
"lymph node":2,
"number of positive central lymph node":1,
"papillary thyroid microcarcinoma":1,
"Fluorodeoxyglucose":1,
"Oncology":1,
"Positron emission tomography":3,
"Staging":1,
"BRAF mutation":3,
"fine-needle aspiration":3,
"hobnail papillary thyroid carcinoma":1,
"hepatitis B virus":1,
"leukemia":2,
"liver cancer":1,
"lymphoma":1,
"Sanger sequencing":1,
"fine-needle aspiration biopsy":2,
"immunohistochemistry":8,
"ultra-deep sequencing":1,
"basement membrane":1,
"collagen type IV":1,
"common marmoset":1,
"thyroid follicular adenoma":1,
"apoptosis":4,
"estrogen receptors":1,
"peroxisome proliferator-activated receptor gamma":1,
"rosiglitazone":1,
"thyroid cancer":24,
"CycD1":1,
"Oct-1":1,
"Octamer-transcription factor-1":1,
"T3":1,
"TH":1,
"TRs":1,
"TRβ1":1,
"Thyroid hormone receptor β1":2,
"cyclin D1":1,
"thyroid hormone":1,
"thyroid hormone receptors":1,
"Annexin A5":1,
"Drug resistance":1,
"Malignancy":2,
"Tumor":1,
"Radiofrequency catheter ablation":1,
"systematic review":1,
"metastasectomy":1,
"metastasis":5,
"thyroid neoplasms/secondary":1,
"thyroid surgery":2,
"Ki67 antigen":1,
"histological labelling":1,
"atypia of undetermined significance":2,
"cytology":4,
"follicular lesion":1,
"thyroid FNA":1,
"BRAFV600E":1,
"Monoclonal antibodies":1,
"Pituitary tumors":1,
"Somatostatin analogs":1,
"Somatostatin receptors":1,
"Lymph node metastasis":2,
"Prognosis":9,
"Survivin":1,
"Tumor stage":1,
"Invasion":2,
"Pituitary adenomas":1,
"Wnt4":1,
"β-Catenin":1,
"Differential diagnosis":1,
"Glandular cardiac myxoma":1,
"Histopathology":2,
"Papillary":1,
"Thyroglossal duct carcinoma":2,
"BRAF V600E mutation":2,
"NIS gene":1,
"histone acetylation":1,
"histone deacetylation":1,
"radioiodine":1,
"Cause of death":1,
"Forensic autopsy":1,
"Lymphocytic hypophysitis":1,
"acute toxicity":1,
"craniospinal irradiation":1,
"proton therapy":1,
"FDG":1,
"PET/CT, ROC":1,
"Computed tomography":1,
"contrast media":1,
"critically appraised topic":1,
"early detection of cancer":1,
"liver":1,
"neoplasm metastasis":5,
"Fatality of thyroid cancer":1,
"Hazard":1,
"Overdiagnosis":2,
"Survival":2,
"Warburg effect":1,
"aerobic glycolysis":1,
"breast cancer":6,
"cancer metabolism":1,
"Akt":1,
"MAPK":1,
"NIS":1,
"TSH receptor":1,
"epigenetics":1,
"Focal adhesion kinase (FAK)":1,
"Migration":1,
"Signal pathway":1,
"Splicing mutant":1,
"c-Src":1,
"APW":1,
"PTH":1,
"aortopulmonary window":1,
"parathyroid hormone":1,
"Abiraterone acetate":1,
"biomarker":2,
"castration-resistant prostate cancer":1,
"hypothyreosis":1,
"Recurrence":3,
"Familial adenomatous polyposis":1,
"Pediatric":1,
"Screening":1,
"Cervical thoracic duct injury":1,
"thoracoscopic approach":1,
"combined high-grade neuroendocrine carcinoma":1,
"large cell neuroendocrine carcinoma":1,
"lung":1,
"small cell carcinoma":1,
"Differentiated thyroid cancer":3,
"Recombinant human thyrotropin":1,
"Remnant ablation":1,
"Thyroid hormone withdrawal":1,
"Differentiated thyroid cancer (DTC)":1,
"MRI":1,
"reoperation":1,
"ultrasonography":4,
"pancreatic metastasis":1,
"Merkel cell carcinoma":1,
"Neuroendocrine tumours":1,
"Submerged goiter":1,
"Diagnosis":4,
"Extrapancreatic malignancies":1,
"Pancreatic cancer":2,
"Therapy":1,
"Internal jugular vein thrombosis":1,
"pulmonary emboli":1,
"upper extremity jugular vein thrombosis":1,
"Ras-related C3 botulinum toxin substrate 1":1,
"microRNA-101":1,
"proliferation":1,
"Epithelial-Mesenchymal Transition":1,
"Extracellular Matrix":3,
"histological grade":1,
"tumor type":1,
"mediastinum":1,
"situs inversus totalis":1,
"Biopsy, fine needle":1,
"Thyroid gland":6,
"Pentetreotide":1,
"Somatostatin":1,
"Somatostatin analogues":1,
"mIBG":1,
"(18)F-Fluorodihydroxyphenylalanine":1,
"Medullary thyroid cancer":1,
"Neuroendocrine tumor":1,
"PET/computed tomography":1,
"Pheochromocytoma":1,
"(18)F-fluorodeoxyglucose (FDG)":1,
"Imaging":2,
"Neuroendocrine tumors (NET)":1,
"Positron emission tomography (PET)":1,
"Extramedullary plasmacytoma":1,
"fine needle aspiration cytology (FNAC)":1,
"medullary carcinoma":1,
"Head and neck malignancy":1,
"Hematoma":1,
"Primary angiosarcoma":1,
"Surgery":1,
"CD-137":1,
"Immunotherapy":1,
"Lung cancer":3,
"PD-1":1,
"PD-L1":1,
"Squamous":1,
"ACB-PCR":1,
"cancer biomarkers":1,
"cancer genetics":1,
"mutation":1,
"oncogenes":1,
"diencephalic":1,
"epilepsy":1,
"leptomeningeal":1,
"sympathetic":1,
"cytohistological correlation":1,
"fine needle aspiration cytology":2,
"indeterminate cytology":1,
"thyroid nodules":2,
"cancer":5,
"central neck dissection":3,
"CT scan":1,
"macroscopic nodal metastasis":1,
"neck dissection":1,
"preoperative radiography":1,
"nasopharyngeal carcinoma":1,
"postradiotherapy":1,
"radiation-induced hypothyroidism":1,
"thyroid antibodies":1,
"thyroid hormones":1,
"Calcium":1,
"Medication":1,
"Postoperative hypoparathyroidism":1,
"Vitamin D(3)":1,
"fine needle aspiration biopsy":2,
"local anesthesia":1,
"neck mass":1,
"pain scale":1,
"ultrasound":4,
"FDG-PET":1,
"radioiodine imaging":1,
"granulomas":1,
"renal cell carcinoma":1,
"thyroid metastases":1,
"Hypoxia inducible factor-1α":1,
"Microvessel count":1,
"Thymidine phosphorylase":1,
"Vascular endothelial growth factor":1,
"Contaminated food commodities":1,
"Endocrine disruptors":1,
"MRL":1,
"Maximum Residue Level":1,
"Molecular markers":1,
"Penconazole":1,
"UC":1,
"untreated cells":1,
"Hypocalcaemia":1,
"Lymph node dissection":1,
"Vocal cord paralysis":1,
"Carcinoma":3,
"ADAM":1,
"Biomarkers":2,
"CR":1,
"CSCs":1,
"Clinical trials":1,
"DLL":1,
"DLT":1,
"Delta-like ligand":1,
"Diarrhea":1,
"EDTA":1,
"GBM":1,
"GSI":1,
"JAG":1,
"Jagged":1,
"MAML":1,
"MSFE":1,
"MTD":1,
"Monoclonal antibodies (mAbs)":1,
"NICD":1,
"NSCLC":1,
"Notch intracellular domain":1,
"Notch signaling":1,
"PD":1,
"PK":1,
"PR":1,
"RECIST":1,
"SD":1,
"T-ALL":1,
"T-LL":1,
"T-cell acute lymphoblastic leukemia":1,
"T-cell lymphoblastic lymphoma":1,
"TACE":1,
"TICs":1,
"a disintegrin and metalloproteases":1,
"cancer stem cells":1,
"complete response":1,
"dose limiting toxicity":1,
"ethylenediaminetetraacetic acid":1,
"glioblastoma multiforme":1,
"mAb":1,
"mammosphere-forming efficiency":1,
"mastermind-like":1,
"maximum tolerated dose":1,
"metalloproteinase tumor necrosis factor-α-converting enzyme":1,
"monoclonal antibody":1,
"non-small cell lung cancer":1,
"partial response":1,
"pharmacodynamics":1,
"pharmacokinetics":1,
"response evaluation criteria in solid tumors":1,
"stable disease":1,
"tumor initiating cells":1,
"γ-Secretase inhibitors":1,
"γ-secretase inhibitor":1,
"delayed bone age":1,
"enlargement of pituitary gland":1,
"enlargement of polycystic ovary":1,
"hypothyroidism":2,
"isosexual precocity":1,
"Hypoxia-inducible factor 1α":1,
"Induced pluripotent stem cells":1,
"Metabolism":2,
"Pyruvate dehydrogenase kinase 1":1,
"Pyruvate kinase isoform M2":1,
"Reprogramming":1,
"bilaterality":1,
"familial non-medullary thyroid cancer":1,
"multi-centricity":1,
"1790T&gt":1,
"A":1,
"BRAF":2,
"DNA yield":1,
"L597Q":1,
"cellularity":1,
"fine-needle aspirate":1,
"molecular cytology":1,
"polymerase chain reaction":1,
"thyroid cytology":1,
"Advanced":1,
"Laryngeal cancer":1,
"Incidental diagnosis":1,
"Papillary microcarcinoma":1,
"Thyroid surgical practices":1,
"Tumor incidence":1,
"growth factors":1,
"microgravity":1,
"protein kinases":1,
"Anaplastic thyroid cancer":2,
"Free radicals":1,
"NAG-1":1,
"Nonsteroidal anti-inflammatory drug-activated gene-1":1,
"Tolfenamic acid":1,
"reactive oxygen species":1,
"caveolin-1":1,
"Cell proliferation":1,
"FNDC5":1,
"Irisin":1,
"LETO":1,
"Long Evans Tokushima Otsuka rats":1,
"Malignant potential":1,
"OLETF":1,
"Obesity-related cancer":1,
"Otsuka Long–Evans Tokushima Fatty rats":1,
"PGC1α":1,
"fibronectin type III domain containing 5":1,
"proliferator-activated receptor gamma co-activator 1-α":1,
"Cellular and molecular rehabilitation":1,
"ER-α":1,
"HIF-1α":1,
"Hypoxia":1,
"Inflammation":1,
"NF-κB":1,
"Reprogramming cancer cells":1,
"molecular targeted therapy":1,
"sorafenib":2,
"tyrosine kinase inhibitors":2,
"Lung sarcomatoid carcinoma":1,
"Napsin":1,
"Autophagy":1,
"Beclin1":1,
"Cisplatin":1,
"miR-30d":1,
"C-cell hyperplasia":1,
"C-cells":1,
"CCH":1,
"CT":2,
"MEN2":1,
"MTC":1,
"Multiple Endocrine Neoplasia type 2":1,
"NF1":1,
"NF1 gene":1,
"Neurofibromatosis type 1":2,
"PKA":1,
"RET gene":1,
"Thyroid C-cell hyperplasia":1,
"calcitonin":1,
"medullary thyroid carcinoma":5,
"parafollicular cells":1,
"protein kinase A":1,
"pattern":1,
"miR-126":1,
"CO(2) laser":1,
"Complication":1,
"Sleeve resection":1,
"Tracheal invasion":1,
"BRAF V600E":1,
"prognostic value":1,
"hypoparathyroidism":1,
"recurrent laryngeal nerve":1,
"mitochondria":1,
"oncocytic tumors":1,
"Azzopardi phenomenon":1,
"H&amp":1,
"E":1,
"basophilic granules":1,
"eosinophilic crystals":1,
"eosinophilic globules":1,
"eosinophilic granules":1,
"hematoxylin body":1,
"hematoxylin–eosin stain":1,
"nuclear inclusion":1,
"nuclear pseudoinclusion":1,
"yellow body":1,
"Access":1,
"incidence":1,
"medical tests":1,
"Radiofrequency ablation":1,
"Real geometrical model":1,
"Thermal lesion estimation":1,
"Trachea lesion":1,
"follicular adenoma":1,
"follicular carcinoma":1,
"general ultrasound":4,
"sonography":3,
"extrathyroidal extension":1,
"predictive factor":1,
"preoperative sonography":1,
"Virtual Touch tissue quantification":1,
"small thyroid nodules":1,
"bisphosphonates":1,
"biszfoszfonátok":1,
"bone metastases":2,
"csontáttét":1,
"denosumab":1,
"external beam radiotherapy":1,
"külső sugárkezelés":1,
"radionuclide therapy":1,
"radionuklidkezelés":1,
"EPIDEMIOLOGY":2,
"PUBLIC HEALTH":1,
"SEER database":1,
"follicular thyroid carcinoma":2,
"molecular classification":1,
"prediction":1,
"quantum dots":2,
"Hashimoto Disease":1,
"Receptors, purinergic P2X7":1,
"Brain":1,
"Cerveaux":1,
"Genetic":1,
"Génétique":1,
"Li-Fraumeni syndrome":1,
"Tumeur":1,
"Tumour":1,
"p53":3,
"Colorectal neoplasms":1,
"Multiple primary cancer":1,
"EGFR/KRAS mutations":1,
"Pulmonary adenocarcinoma":1,
"clinicopathologic features":1,
"enteric":1,
"Cancer stem cell niche":1,
"Mesenchymal cells":1,
"Tumour microenvironment":1,
"Tumour xenografts":1,
"G691S/S904S haplotype":1,
"Medullary":1,
"RET proto-oncogene":1,
"Right thyroid hemiagenesis, Parathyroid adenoma, Primary hyperparathyroidism":1,
"Northern Cyprus":1,
"cost":1,
"treatment":1,
"thyroid-like follicular carcinoma of the kidney renal cell carcinoma":1,
"Cohort study":1,
"Exposure assessment":1,
"Occupational exposure":1,
"Polychlorinated biphenyls":1,
"CI-1040":1,
"PP2":1,
"SU6656":1,
"dasatinib":1,
"anaplastic thyroid carcinoma":2,
"multicenter registry":1,
"prognostic factor":1,
"quality of life":2,
"super-radical surgery":1,
"Hürthle cell adenoma":1,
"calcification":1,
"neck":2,
"breast carcinoma":1,
"pulmonary carcinoma":1,
"CCL18":1,
"INTEGRIN":1,
"Pyk2":1,
"Src":1,
"Cáncer de tiroides":1,
"Embarazo":1,
"Guideline":1,
"Guía":1,
"Nódulo tiroideo":1,
"Pregnancy":1,
"Bethesda":1,
"atypical":1,
"terminology":1,
"Thyroglossal duct":1,
"Thyroglossal duct cyst":1,
"REACTION study":1,
"diabetes":1,
"肿瘤，糖尿病，REACTION研究":1,
"vandetanib":1,
"Chromosomal translocation":1,
"FGFR1OP-RET":1,
"Mast cells":1,
"Murine models":1,
"Myeloproliferative disorders":1,
"Chernobyl":1,
"NTRK3":1,
"chromosomal rearrangements":1,
"radiation":1,
"Diffusion-weighted imaging":1,
"sensitivity":1,
"specificity":1,
"Double primary malignancy":1,
"Gastric cancer":1,
"Microsatellite instability":1,
"Adenocarcinoma":1,
"Epidermal growth factor receptor":1,
"Pulmonary surfactant-associated protein":1,
"Thyroid transcription factor-1":1,
"Color Doppler ultrasound":1,
"Sonoelastography":1,
"Strain ratio":2,
"Elastography":2,
"Nodule":1,
"CI":1,
"IL-21":1,
"MAF":1,
"OR":1,
"Polymorphisms":1,
"SNP":1,
"confidence interval":1,
"minor allele frequency":1,
"odds ratio":1,
"single nucleotide polymorphism":1,
"Hashimoto's thyroiditis":2,
"Metastatic burden":1,
"Multi-nodular goiter":1,
"Thyroiditis":2,
"US":1,
"hypopharyngeal cancer":1,
"End-stage renal disease":1,
"Hyperparathyroidism":1,
"Size":1,
"3,5,3′ Triiodothyronine":1,
"MiR-224":1,
"MiR-452":1,
"MicroRNA":1,
"Renal cancer":1,
"Type 1 5′-iodothyronine deiodinase":1,
"miRNA profiling":1,
"poorly differentiated carcinoma":1,
"blood activity":1,
"dynamic PET":1,
"micro-pipette":1,
"thyroid probe":1,
"well counter":1,
"CAF":1,
"GPER":2,
"tamoxifen resistance":1,
"Diagnostic test":1,
"Dog":1,
"Sepsis":1,
"Validation":1,
"Extrapulmonary malignancy":1,
"Frequency":1,
"Metastatic malignancy":1,
"Primary lung adenocarcinoma":1,
"outcome":1,
"matrix metalloproteinases":1,
"tissue inhibitor of metalloproteinase":1,
"ATF3":1,
"Agonistic anti-DR5 antibody":1,
"DR5":1,
"ER stress":1,
"HDACI":1,
"macrocalcification":1,
"Adverse effects":1,
"Chemotherapy":1,
"Response rate":1,
"elasticity score":1,
"Atypia":1,
"Loss of heterozygosity":1,
"Tumor suppressor genes":1,
"hypophysitis":1,
"immune-related adverse effects":1,
"ipilimumab":1,
"nivolumab":1,
"Cyclooxygenase-2":1,
"P-glycoprotein":1,
"VEGF":1,
"Neoplasms":2,
"Non-Spine":1,
"color doppler ultrasounds":1,
"iodine 123 congenital hypothyroidism":1,
"thyroid autonomy":1,
"thyroid scintigraphy":1,
"thyrotoxicosis":1,
"children":1,
"thyroid ultrasound":1,
"Ki67":1,
"disease-free survival":1,
"Urinary bladder neoplasms":1,
"Akt inhibitor":1,
"PDGFR inhibitor":1,
"additive effect":1,
"motility":1,
"synergy":1,
"viability":1,
"Ablation":1,
"Iodides":1,
"Radioactivity":1,
"Curcumin":1,
"Cyclooxygenase 2":1,
"Docetaxel":1,
"NF-kappa B":1,
"Thyroid cancer, anaplastic":1,
"Hyponatremia":1,
"ACTH syndrome, ectopic":1,
"Cushing syndrome":1,
"iodine-131":1,
"Breast neoplasms":3,
"Treatment outcome":1,
"Extranodal":1,
"Non-hodgkin":1,
"131I scan":1,
"Adrenal metastasis":1,
"Fluorodeoxyglucose F18":1,
"Fused positron emission tomography and computerized tomography":1,
"Ascites":1,
"Ca Ovary":1,
"Ca-125":1,
"Struma Ovarii":1,
"IASLC/ATS/ERS classification":1,
"Napsin A":1,
"Stage I":1,
"TTF1":1,
"HRAS":1,
"PTEN":1,
"Quadruple cancers":1,
"multiple sclerosis":1,
"Fluorodeoxyglucose F-18":1,
"Magnetic resonance imaging":1,
"Positron emission tomography and computed tomography":1,
"DICER1":1,
"Sertoli-Leydig":1,
"nasal chondromesenchymal hamartoma":1,
"pleuropulmonary blastoma":1,
"pleural effusion":1,
"pleural metastasis":1,
"thoracoscopy under local anesthesia":1,
"Second primary neoplasms":1,
"Korea":1,
"Validity":1,
"CAFs":1,
"Estrogenic effects":1,
"Tumor microenvironment":1,
"Carcinoma, Medullary":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2014年第1季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
